Permanent Gentamicin Vestibulotoxicity

@article{Black2004PermanentGV,
  title={Permanent Gentamicin Vestibulotoxicity},
  author={Franklin O. Black and Susan C Pesznecker and Valerie L. Stallings},
  journal={Otology \& Neurotology},
  year={2004},
  volume={25},
  pages={559-569}
}
Objective: To determine the natural history of permanent gentamicin vestibulotoxicity. Study Design: Retrospective; comparison of retrospective and prospective studies. Setting: Tertiary neurotology clinic. Clinical research and technology center. Subjects: Thirty-three subjects with permanent gentamicin-induced vestibulotoxicity. Interventions: Medical records review, neurotologic examination, and vestibular and auditory function tests. Main Outcome Measures: Vestibular and auditory function… 
Gentamicin Vestibulotoxicity: Further Insights From a Large Clinical Series.
  • Terence S. Fu, S. Carr, J. Rutka
  • Medicine
    Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
  • 2020
TLDR
While SDD is associated with decreased risk for nephrotoxicity compared with MDD, it confers a higher risk for vestibulotoxicity, which further highlights important insights regarding gentamicin-induced vestibular dysfunction.
Gentamicin vestibulotoxicity with modern systemic dosing regimens: a prospective study using video-oculography
TLDR
Gentamicin may cause reversible, asymptomatic vestibulotoxicity in patients treated with gentamicin, and video-oculography may be useful to monitor for vestibular loss in patients treating with gentamcin; however, testing all patients routinely may be challenging.
Gentamicin ototoxicity: clinical features and the effect on the human vestibulo-ocular reflex
TLDR
A retrospective review of the quantitative vestibular function testing results for patients presenting to the UCLA Neurotology Clinic with gentamicin ototoxicity over the past 10 years found that sinusoidal rotational stimuli with high accelerations such as the bedside head-thrust test or rotational step changes in velocity are useful to diagnose bilateral vestibulopathy.
Hearing loss in patients with vestibulotoxic reactions to gentamicin therapy.
TLDR
Patients with vestibulotoxic reactions to gentamicin therapy have little additional hearing loss compared with the general population, and Physicians should monitor both auditory and audiometric function when aminoglycosides, especially gentamicine, must be used.
Systemic Aminoglycosides-Induced Vestibulotoxicity in Humans
TLDR
Video Head Impulse test and vestibular evoked myogenic potential testing seem more promising for the early detection of vestibulotoxic side effects than caloric and rotatory testing.
Intratympanic gentamicin in monolateral Meniere’s disease: our experience
TLDR
The marker of successful gentamicin treatment at short-term is the appearance of signs of curative vertigo and/or vestibular imbalance, and at long-term the disappearance of vertigo attacks.
Vestibulotoxicity: strategies for clinical diagnosis and rehabilitation
TLDR
Evidence suggests that including assessment of vestibular function in a programme to monitor for ototoxic damage is essential, and the need for further study is stressed to determine an ideal protocol for assessing Vestibular system function during and following exposure to toxic agents.
Retrospective review of oscillopsia: etiologies and clinical characteristics
TLDR
A wide spectrum of clinical characteristics was identified in patients with oscillopsia, and it is important for the physician to perform a thorough history, physical examination, and laboratory investigations.
Prevention of Severe Vestibular Hypofunction after Systemic Gentamicin
TLDR
Evaluation of vestibular function should be included in the infective endocarditis treatment protocol, including the adverse effects of systemic gentamicin.
Instability Due to Drug-Induced Vestibulotoxicity.
TLDR
It is important to ensure an early diagnosis to prevent ototoxic effects induced by drugs, and it is recommended that patients receiving potential otot toxic drugs undergo cochlear and vestibular assessments.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 42 REFERENCES
Recovery from Vestibular Ototoxicity
  • F. O. Black, C. Gianna-Poulin, S. Pesznecker
  • Medicine
    Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
  • 2001
TLDR
Recovery of GC after vestibular ototoxicity is more commonly observed than recovery of TC, and it is proposed that once ototoxic changes in vestibulo-ocular reflex are detected, otot toxic medications should be discontinued as soon as possible.
Gentamicin Vestibulotoxicity
TLDR
It is concluded that as far as the vestibular system is concerned there is no safe gentamicin dose and no safe serum Gentamicin level, and there is an increased risk of vestibulotoxicity in patients in whom nephrotoxicity develops.
A prospective study of gentamicin ototoxicity.
TLDR
Gentamicin should be used only as a link in the primary treatment of severe infection or in cases in which other, less toxic agents have failed, according to a prospective otoneurological study performed.
Unilateral vestibulotoxicity due to systemic gentamicin therapy.
TLDR
6 patients presenting with ataxia and oscillopsia, but without a history of vertigo, who had severe unilateral loss of vestibular function on caloric testing are reported, supported by the observation that Vestibular hair cells can regenerate after aminoglycoside damage.
Predictive monitoring of high-frequency vestibulo-ocular reflex rehabilitation following gentamicin ototoxicity.
TLDR
It is concluded that predictive monitoring of changing VOR states can be useful for continuing, or modifying, the course of vestibular rehabilitation therapy, by providing quantitative prediction estimates of future results.
A controlled study of the reliability of pure tone audiometry for the detection of gentamicin auditory toxicity.
TLDR
It was concluded that aminoglycoside auditory toxicity should not be assessed retrospectively and recommendations are made for the conduct of future studies of drug-induced auditory toxicity.
Tympanic electrocochleography for diagnosis of Menière's disease.
OBJECTIVE Tympanic electrocochleography (ECOG) is a noninvasive technique for recording cochlear potentials with an electrode placed on the tympanic membrane. Electrocochleography is used clinically
Comparison of Vestibular Autorotation and Caloric Testing
Vestibular reflex changes following aminoglycoside induced ototoxicity
The effects of aminoglycoside‐induced changes on the vestibular system were evaluated in three subjects who suffered significant damage over the course of treatment. Measurements of vestibulo‐ocular
Clinical monitoring using otoacoustic emissions.
TLDR
Preliminary studies in humans demonstrate that cochlear damage due to ototoxic drugs such as aminoglycosides or cisplatin and due to noise exposure can be detected using otoacoustic emissions.
...
1
2
3
4
5
...